Cell-Penetrating Peptides-Based Strategies for the Delivery of Splice Redirecting Antisense Oligonucleotides

Methods in Molecular Biology

Volumn 764, Issue , 2011, Pages 75-89

  El Andaloussi, Samir ^a   Said Hassane, Fatouma ^b   Boisguerin, Prisca ^b,c   Sillard, Rannar ^a   Langel, Ülo ^a   Lebleu, Bernard ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antisense oligonucleotides; cell penetrating peptides; delivery; splicing redirection

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL PENETRATING PEPTIDE; LUCIFERASE; MESSENGER RNA; STEARIC ACID; STEARIC ACID DERIVATIVE;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; BIOASSAY; BIOSYNTHESIS; CELL NUCLEUS; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; FLOW CYTOMETRY; GENETICS; HELA CELL; HUMAN; MACROMOLECULE; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BIOLOGICAL ASSAY; CELL NUCLEUS; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; FEMALE; FLOW CYTOMETRY; GENES, REPORTER; HELA CELLS; HUMANS; LUCIFERASES; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEARIC ACIDS;

EID: 79960947112     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-188-8_5     Document Type: Chapter

References (23)

1. Juliano, R., Bauman, J., Kang, H., and Ming, X. (2009) Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol Pharm. 6, 686–695.
2. Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Nordén, B., and Nielsen, P. E. (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365, 566–568.
3. Summerton, J. (1999) Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim Biophys Acta 1489, 141–158.
4. Ng, E. W., Shima, D. T., Calias, P., Cunningham, E. T., Jr., Guyer, D. R., and Adamis, A. P. (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov. 5, 123–132.
5. Barchet, W., Wimmenauer, V., Schlee, M., and Hartmann, G. (2008) Accessing the therapeutic potential of immunostimulatory nucleic acids. Curr Opin Immunol. 20, 389–395.
6. Aartsma-Rus, A., Fokkema, I., Verschuuren, J., Ginjaar, I., van Deutekom, J., van Ommen, G. J., and den Dunnen, J. T. (2009) Theoretic applicability of antisense-mediated exon skipping for duchenne muscular dystrophy mutations. Hum Mutat. 30, 293–299.
7. Juliano, R., Alam, M. R., Dixit, V., and Kang, H. (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res. 36, 4158–4171.
8. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the antennapedia homeodomain translocates through biological membranes. J Biol Chem. 269, 10444–10450.
9. Vivés, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 272, 16010–16017.
10. Mäe, M., El-Andaloussi, S., Lehto, T., and Langel, Ü. (2009) Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Expert Opin Drug Deliv. 6, 1195–1205.
11. Nakase, I., Takeuchi, T., Tanaka, G., and Futaki, S. (2008) Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv Drug Deliv Rev. 60, 598–607.
12. Fonseca, S. B., Pereira, M. P., and Kelley, S. O. (2009) Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev. 61, 953–964.
13. Said Hassane, F., Saleh, A., Abes, R., Gait, M. J., and Lebleu, B. (2010) Cell penetrating peptides and their applications: an overview. Cell Mol Life Sci. 67, 715–728.
14. Abes, S., Williams, D., Prevot, P., Thierry, A., Gait, M. J., and Lebleu, B. (2006) Endo-some trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates. J Control Release 110, 595–604.
15. Lebleu, B., Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, D. A., Iversen, P. L., Arzumanov, A. A., and Gait, M. J. (2008) Cell penetrating peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev. 60, 517–529.
16. Kang, S. H., Cho, M. J., and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 37, 6235–6239.
17. Abes, R., Moulton, H. M., Clair, P., Yang, S. T., Abes, S., Melikov, K., Prevot, P., Youngblood, D. S., Iversen, P. L., Chernomordik, L. V., and Lebleu, B. (2008) Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies. Nucleic Acids Res. 36, 6343– 6354.
18. Jearawiriyapaisarn, N., Moulton, H. M., Buckley, B., Roberts, J., Sazani, P., Fucharoen, S., Iversen, P. L., and Kole, R. (2008) Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol Ther. 16, 1624–1629.
19. Yin, H., Moulton, H. M., Seow, Y., Boyd, C., Boutilier, J., Iverson, P., and Wood, M. J. (2008) Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum Mol Genet. 17, 3909–3918.
20. Lehto, T., Abes, R., Oskolkov, N., Suho-rutsenko, J., Copolovici, D. M., Mäger, I., Viola, J. R., Simonson, O., Guterstam, P., Eriste, E., Smith, C. I., Lebleu, B., El-Andaloussi, S., and Langel, Ü. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy. J Control Release 141, 42–51.
21. Kilk, K., and Langel, Ü. (2005) Cellular delivery of peptide nucleic acid by cell-penetrating peptides. Methods Mol Biol. 298, 131–141.
22. Pooga, M., Soomets, U., Bartfai, T., and Langel, Ü. (2002) Synthesis of cell-penetrating peptide-PNA constructs. Methods Mol Biol. 208, 225–236.
23. Bernatowicz, M. S., Matsueda, R., and Matsueda, G. R. (1986) Preparation of Boc-[S-(3-nitro-2-pyridinesulfenyl)]-cysteine and its use for unsymmetrical disulfide bond formation. Int J Pept Protein Res. 28, 107–112.